{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T15:00:33Z","timestamp":1763564433322,"version":"3.41.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T00:00:00Z","timestamp":1746835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T00:00:00Z","timestamp":1746835200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-025-02758-6","type":"journal-article","created":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T17:25:32Z","timestamp":1746897932000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Reducing the effective dosage of Mitomycin C on a high-grade bladder cancer cell line through combination with selenium nanoparticles: An in vitro study"],"prefix":"10.1007","volume":"42","author":[{"given":"Iman Menbari","family":"Oskouie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein","family":"Amirzargar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amin Shiralizadeh","family":"Dezfuli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahil","family":"Mashhadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akram","family":"Mirzaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amirreza","family":"Shamshirgaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parsa","family":"Nikoofar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Mohammad Kazem","family":"Aghamir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,10]]},"reference":[{"key":"2758_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA cancer J Clin. 2024;74:229\u201363.","journal-title":"CA cancer J Clin"},{"key":"2758_CR2","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41571-023-00744-3","volume":"20","author":"LM van Hoogstraten","year":"2023","unstructured":"van Hoogstraten LM, Vrieling A, van der Heijden AG, Kogevinas M, Richters A, Kiemeney LA. Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice. Nat Rev Clin Oncol. 2023;20:287\u2013304.","journal-title":"Nat Rev Clin Oncol"},{"key":"2758_CR3","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41572-023-00468-9","volume":"9","author":"L Dyrskj\u00f8t","year":"2023","unstructured":"Dyrskj\u00f8t L, Hansel DE, Efstathiou JA, Knowles MA, Galsky MD, Teoh J, et al. Bladder cancer. Nature Rev Dis Prim. 2023;9:58.","journal-title":"Nature Rev Dis Prim"},{"key":"2758_CR4","doi-asserted-by":"publisher","first-page":"S46","DOI":"10.1089\/end.2020.1068","volume":"35","author":"L Defidio","year":"2021","unstructured":"Defidio L, Antonucci M, Castellani D, Civitella A, Esperto F, Scarpa RM. Transurethral resection of bladder tumor: electrosurgical and laser. J Endourol. 2021;35:S46-51.","journal-title":"J Endourol"},{"key":"2758_CR5","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.euo.2020.06.010","volume":"4","author":"H Mostafid","year":"2021","unstructured":"Mostafid H, Kamat AM, Daneshmand S, Palou J, Taylor JA III, McKiernan J, et al. Best practices to optimise quality and outcomes of transurethral resection of bladder tumours. Eur Urol Oncol. 2021;4:12\u20139.","journal-title":"Eur Urol Oncol"},{"key":"2758_CR6","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.juro.2016.06.049","volume":"196","author":"SS Chang","year":"2016","unstructured":"Chang SS, Boorjian SA, Chou R, Clark PE, Daneshmand S, Konety BR, et al. Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline. J Urol. 2016;196:1021\u20139.","journal-title":"J Urol"},{"key":"2758_CR7","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1097\/01.ju.0000125486.92260.b2","volume":"171","author":"RJ Sylvester","year":"2004","unstructured":"Sylvester RJ, Oosterlinck W, van der Meijden AP. A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials. J Urol. 2004;171:2186\u201390.","journal-title":"J Urol"},{"key":"2758_CR8","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.eururo.2013.06.009","volume":"64","author":"N Perlis","year":"2013","unstructured":"Perlis N, Zlotta AR, Beyene J, Finelli A, Fleshner NE, Kulkarni GS. Immediate post\u2013transurethral resection of bladder tumor intravesical chemotherapy prevents non\u2013muscle-invasive bladder cancer recurrences: an updated meta-analysis on 2548 patients and quality-of-evidence review. Eur Urol. 2013;64:421\u201330.","journal-title":"Eur Urol"},{"key":"2758_CR9","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/bju.15571","volume":"129","author":"Y Miyata","year":"2022","unstructured":"Miyata Y, Tsurusaki T, Hayashida Y, Imasato Y, Takehara K, Aoki D, et al. Intravesical mitomycin C (MMC) and MMC+ cytosine arabinoside for non-muscle-invasive bladder cancer: a randomised clinical trial. BJU Int. 2022;129:534\u201341.","journal-title":"BJU Int"},{"key":"2758_CR10","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1046\/j.1464-410x.1999.00951.x","volume":"83","author":"S Doherty","year":"1999","unstructured":"Doherty S, Rogers B. Perivesical fat necrosis after adjuvant intravesical chemotherapy. BJU Int. 1999;83:420\u20133.","journal-title":"BJU Int"},{"key":"2758_CR11","first-page":"40.e1","volume":"32","author":"CP Filson","year":"2014","unstructured":"Filson CP, Montgomery JS, Dailey SM, Crossley HS, Lentz H, Tallman CT, et al. Complications associated with single-dose, perioperative mitomycin-C for patients undergoing bladder tumor resection. Urol Oncol Sem Orig Invest. 2014;32:40.e1-e8.","journal-title":"Urol Oncol Sem Orig Invest"},{"key":"2758_CR12","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.3390\/molecules27082486","volume":"27","author":"A Sentkowska","year":"2022","unstructured":"Sentkowska A, Pyrzy\u0144ska K. The influence of synthesis conditions on the antioxidant activity of selenium nanoparticles. Molecules. 2022;27:2486.","journal-title":"Molecules"},{"key":"2758_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.123261","volume":"232","author":"X Wang","year":"2023","unstructured":"Wang X, Liu W, Li Y, Ma L, Lin Z, Xu J, et al. Preparation and anti-tumor activity of selenium nanoparticles based on a polysaccharide from Paeonia lactiflora. Int J Biol Macromol. 2023;232: 123261.","journal-title":"Int J Biol Macromol"},{"key":"2758_CR14","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.1039\/D0NJ05884J","volume":"45","author":"V Nayak","year":"2021","unstructured":"Nayak V, Singh KR, Singh AK, Singh RP. Potentialities of selenium nanoparticles in biomedical science. New J Chem. 2021;45:2849\u201378.","journal-title":"New J Chem"},{"key":"2758_CR15","doi-asserted-by":"publisher","first-page":"1183487","DOI":"10.3389\/fnut.2023.1183487","volume":"10","author":"T Zhang","year":"2023","unstructured":"Zhang T, Qi M, Wu Q, Xiang P, Tang D, Li Q. Recent research progress on the synthesis and biological effects of selenium nanoparticles. Front Nutr. 2023;10:1183487.","journal-title":"Front Nutr"},{"key":"2758_CR16","doi-asserted-by":"publisher","first-page":"25857","DOI":"10.1021\/acsami.7b07167","volume":"9","author":"Y Yang","year":"2017","unstructured":"Yang Y, Xie Q, Zhao Z, He L, Chan L, Liu Y, et al. Functionalized selenium nanosystem as radiation sensitizer of 125I seeds for precise cancer therapy. ACS Appl Mater Interfaces. 2017;9:25857\u201369.","journal-title":"ACS Appl Mater Interfaces"},{"key":"2758_CR17","doi-asserted-by":"publisher","first-page":"11177","DOI":"10.1021\/acsami.8b22678","volume":"11","author":"J Huang","year":"2019","unstructured":"Huang J, Huang W, Zhang Z, Lin X, Lin H, Peng L, et al. Highly uniform synthesis of selenium nanoparticles with EGFR targeting and tumor microenvironment-responsive ability for simultaneous diagnosis and therapy of nasopharyngeal carcinoma. ACS Appl Mater Interfaces. 2019;11:11177\u201393.","journal-title":"ACS Appl Mater Interfaces"},{"key":"2758_CR18","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1002\/anie.201914453","volume":"59","author":"T Li","year":"2020","unstructured":"Li T, Pan S, Gao S, Xiang W, Sun C, Cao W, et al. Diselenide-Pemetrexed assemblies for combined cancer Immuno-, radio-, and chemotherapies. Angew Chem Int Ed. 2020;59:2700\u20134.","journal-title":"Angew Chem Int Ed"},{"key":"2758_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2020.100975","volume":"35","author":"T Liu","year":"2020","unstructured":"Liu T, Xu L, He L, Zhao J, Zhang Z, Chen Q, et al. Selenium nanoparticles regulates selenoprotein to boost cytokine-induced killer cells-based cancer immunotherapy. Nano Today. 2020;35: 100975.","journal-title":"Nano Today"},{"key":"2758_CR20","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.saa.2017.11.050","volume":"192","author":"AV Tugarova","year":"2018","unstructured":"Tugarova AV, Mamchenkova PV, Dyatlova YA, Kamnev AA. FTIR and Raman spectroscopic studies of selenium nanoparticles synthesised by the bacterium Azospirillum thiophilum. Spectrochim Acta Part A Mol Biomol Spectrosc. 2018;192:458\u201363.","journal-title":"Spectrochim Acta Part A Mol Biomol Spectrosc"},{"key":"2758_CR21","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jphotobiol.2018.12.008","volume":"191","author":"LY Cruz","year":"2019","unstructured":"Cruz LY, Wang D, Liu J. Biosynthesis of selenium nanoparticles, characterization and X-ray induced radiotherapy for the treatment of lung cancer with interstitial lung disease. J Photochem Photobiol B. 2019;191:123\u20137.","journal-title":"J Photochem Photobiol B"},{"key":"2758_CR22","doi-asserted-by":"publisher","first-page":"6841","DOI":"10.2147\/IJN.S139212","volume":"12","author":"SA Wadhwani","year":"2017","unstructured":"Wadhwani SA, Gorain M, Banerjee P, Shedbalkar UU, Singh R, Kundu GC, et al. Green synthesis of selenium nanoparticles using Acinetobacter sp SW30: optimization, characterization and its anticancer activity in breast cancer cells. Int J Nanomed. 2017;12:6841\u201355.","journal-title":"Int J Nanomed"},{"key":"2758_CR23","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S82707","author":"MS Ahmad","year":"2015","unstructured":"Ahmad MS, Yasser MM, Sholkamy EN, Ali AM, Mehanni MM. Anticancer activity of biostabilized selenium nanorods synthesized by Streptomyces bikiniensis strain Ess_amA-1. International journal of nanomedicine. 2015. https:\/\/doi.org\/10.2147\/IJN.S82707.","journal-title":"International journal of nanomedicine"},{"key":"2758_CR24","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1002\/btpr.1992","volume":"30","author":"P Srivastava","year":"2014","unstructured":"Srivastava P, Braganca JM, Kowshik M. In vivo synthesis of selenium nanoparticles by Halococcus salifodinae BK18 and their anti-proliferative properties against HeLa cell line. Biotechnol Prog. 2014;30:1480\u20137.","journal-title":"Biotechnol Prog"},{"key":"2758_CR25","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/BF00299720","volume":"20","author":"P Rajala","year":"1992","unstructured":"Rajala P, Kaasinen E, Rintala E, Jauhiainen K, Nurmi M, Alfthan O, et al. Cytostatic effect of different strains of Bacillus Calmette-Gu\u00e9rin on human bladder cancer cells in vitro alone and in combination with mitomycin C and Interferon-\u03b1. Urol Res. 1992;20:215\u20137.","journal-title":"Urol Res"},{"key":"2758_CR26","doi-asserted-by":"publisher","first-page":"35.e15","DOI":"10.1016\/j.urolonc.2013.01.009","volume":"32","author":"AJ Lightfoot","year":"2014","unstructured":"Lightfoot AJ, Breyer BN, Rosevear HM, Erickson BA, Konety BR, O\u2019Donnell MA. Multi-institutional analysis of sequential intravesical gemcitabine and mitomycin C chemotherapy for non\u2013muscle invasive bladder cancer. Urologic Oncol Sem Orig Invest. 2014;32:35.e15-35.","journal-title":"Urologic Oncol Sem Orig Invest"},{"key":"2758_CR27","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1111\/bju.13088","volume":"117","author":"PA Cockerill","year":"2016","unstructured":"Cockerill PA, Knoedler JJ, Frank I, Tarrell R, Karnes RJ. Intravesical gemcitabine in combination with mitomycin C as salvage treatment in recurrent non-muscle-invasive bladder cancer. BJU Int. 2016;117:456\u201362.","journal-title":"BJU Int"},{"key":"2758_CR28","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/nrurol.2014.52","volume":"11","author":"H Zargar","year":"2014","unstructured":"Zargar H, Aning J, Ischia J, So A, Black P. Optimizing intravesical mitomycin C therapy in non-muscle-invasive bladder cancer. Nat Rev Urol. 2014;11:220\u201330.","journal-title":"Nat Rev Urol"},{"key":"2758_CR29","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1007\/s00449-015-1413-8","volume":"38","author":"N Srivastava","year":"2015","unstructured":"Srivastava N, Mukhopadhyay M. Green synthesis and structural characterization of selenium nanoparticles and assessment of their antimicrobial property. Bioprocess Biosyst Eng. 2015;38:1723\u201330.","journal-title":"Bioprocess Biosyst Eng"},{"key":"2758_CR30","unstructured":"Kirupagaran R, Saritha A, Bhuvaneswari S. Green synthesis of selenium nanoparticles from leaf and stem extract of Leucas lavandulifolia Sm. and their application. Journal of Nanoscience and Technology. 2016: 224\u20136."},{"key":"2758_CR31","first-page":"9","volume":"4","author":"H Azodian Ghajar","year":"2022","unstructured":"Azodian Ghajar H, Koohi OR. The promising role of MicroRNAs, long non-coding RNAs and circular RNAs in urological malignancies. Translational Research in Urology. 2022;4:9\u201323.","journal-title":"Translational Research in Urology"},{"key":"2758_CR32","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.ejpb.2008.11.010","volume":"71","author":"H Maeda","year":"2009","unstructured":"Maeda H, Bharate G, Daruwalla J. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect. Eur J Pharm Biopharm. 2009;71:409\u201319.","journal-title":"Eur J Pharm Biopharm"},{"key":"2758_CR33","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/10611860701539584","volume":"15","author":"K Greish","year":"2007","unstructured":"Greish K. Enhanced permeability and retention of macromolecular drugs in solid tumors: a royal gate for targeted anticancer nanomedicines. J Drug Target. 2007;15:457\u201364.","journal-title":"J Drug Target"},{"key":"2758_CR34","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0168-3659(99)00248-5","volume":"65","author":"H Maeda","year":"2000","unstructured":"Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release. 2000;65:271\u201384.","journal-title":"J Control Release"},{"key":"2758_CR35","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S1567-5769(02)00271-0","volume":"3","author":"H Maeda","year":"2003","unstructured":"Maeda H, Fang J, Inutsuka T, Kitamoto Y. Vascular permeability enhancement in solid tumor: various factors, mechanisms involved and its implications. Int Immunopharmacol. 2003;3:319\u201328.","journal-title":"Int Immunopharmacol"},{"key":"2758_CR36","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nrd1088","volume":"2","author":"R Duncan","year":"2003","unstructured":"Duncan R. The dawning era of polymer therapeutics. Nat Rev Drug Discovery. 2003;2:347\u201360.","journal-title":"Nat Rev Drug Discovery"},{"key":"2758_CR37","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/jac\/dks379","volume":"68","author":"EA Azzopardi","year":"2013","unstructured":"Azzopardi EA, Ferguson EL, Thomas DW. The enhanced permeability retention effect: a new paradigm for drug targeting in infection. J Antimicrob Chemother. 2013;68:257\u201374.","journal-title":"J Antimicrob Chemother"},{"key":"2758_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2019.05.031","volume":"216","author":"L Zheng","year":"2019","unstructured":"Zheng L, Huang X, Lin X, Lin W, Yang F, Chen T. Thermosensitive hydrogels for sustained-release of sorafenib and selenium nanoparticles for localized synergistic chemoradiotherapy. Biomaterials. 2019;216: 119220.","journal-title":"Biomaterials"},{"key":"2758_CR39","first-page":"947","volume":"11","author":"T Liu","year":"2015","unstructured":"Liu T, Zeng L, Jiang W, Fu Y, Zheng W, Chen T. Rational design of cancer-targeted selenium nanoparticles to antagonize multidrug resistance in cancer cells. Nanomedicine: nanotechnology. Biol Med. 2015;11:947\u201358.","journal-title":"Biol Med"},{"key":"2758_CR40","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1093\/toxsci\/kfm221","volume":"101","author":"J Zhang","year":"2008","unstructured":"Zhang J, Wang X, Xu T. Elemental selenium at nano size (Nano-Se) as a potential chemopreventive agent with reduced risk of selenium toxicity: comparison with se-methylselenocysteine in mice. Toxicol Sci. 2008;101:22\u201331.","journal-title":"Toxicol Sci"},{"key":"2758_CR41","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1016\/j.freeradbiomed.2007.02.013","volume":"42","author":"H Wang","year":"2007","unstructured":"Wang H, Zhang J, Yu H. Elemental selenium at nano size possesses lower toxicity without compromising the fundamental effect on selenoenzymes: comparison with selenomethionine in mice. Free Radical Biol Med. 2007;42:1524\u201333.","journal-title":"Free Radical Biol Med"},{"key":"2758_CR42","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/biof.5520150103","volume":"15","author":"J-S Zhang","year":"2001","unstructured":"Zhang J-S, Gao X-Y, Zhang L-D, Bao Y-P. Biological effects of a nano red elemental selenium. BioFactors. 2001;15:27\u201338.","journal-title":"BioFactors"},{"key":"2758_CR43","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.lfs.2004.08.015","volume":"76","author":"J Zhang","year":"2005","unstructured":"Zhang J, Wang H, Yan X, Zhang L. Comparison of short-term toxicity between Nano-Se and selenite in mice. Life Sci. 2005;76:1099\u20139.","journal-title":"Life Sci"},{"key":"2758_CR44","doi-asserted-by":"publisher","first-page":"7106","DOI":"10.1016\/j.biomaterials.2013.04.067","volume":"34","author":"Y Huang","year":"2013","unstructured":"Huang Y, He L, Liu W, Fan C, Zheng W, Wong Y-S, et al. Selective cellular uptake and induction of apoptosis of cancer-targeted selenium nanoparticles. Biomaterials. 2013;34:7106\u201316.","journal-title":"Biomaterials"},{"key":"2758_CR45","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1039\/C5TB02710A","volume":"4","author":"T Nie","year":"2016","unstructured":"Nie T, Wu H, Wong K-H, Chen T. Facile synthesis of highly uniform selenium nanoparticles using glucose as the reductant and surface decorator to induce cancer cell apoptosis. J Mater Chem B. 2016;4:2351\u20138.","journal-title":"J Mater Chem B"},{"key":"2758_CR46","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00280-008-0745-3","volume":"63","author":"N Xiang","year":"2009","unstructured":"Xiang N, Zhao R, Zhong W. Sodium selenite induces apoptosis by generation of superoxide via the mitochondrial-dependent pathway in human prostate cancer cells. Cancer Chemother Pharmacol. 2009;63:351\u201362.","journal-title":"Cancer Chemother Pharmacol"},{"key":"2758_CR47","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.colsurfb.2012.02.006","volume":"94","author":"H Luo","year":"2012","unstructured":"Luo H, Wang F, Bai Y, Chen T, Zheng W. Selenium nanoparticles inhibit the growth of HeLa and MDA-MB-231 cells through induction of S phase arrest. Colloids Surf, B. 2012;94:304\u20138.","journal-title":"Colloids Surf, B"},{"key":"2758_CR48","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1158\/0008-5472.CAN-03-2789","volume":"64","author":"Y Dong","year":"2004","unstructured":"Dong Y, Lee SO, Zhang H, Marshall J, Gao AC, Ip C. Prostate specific antigen expression is down-regulated by selenium through disruption of androgen receptor signaling. Can Res. 2004;64:19\u201322.","journal-title":"Can Res"},{"key":"2758_CR49","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ijbiomac.2017.03.033","volume":"101","author":"D Chen","year":"2017","unstructured":"Chen D, Sun S, Cai D, Kong G. Induction of mitochondrial-dependent apoptosis in T24 cells by a selenium (Se)-containing polysaccharide from Ginkgo biloba L. leaves. Int J Biol Macromol. 2017;101:126\u201330.","journal-title":"Int J Biol Macromol"},{"key":"2758_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.adcanc.2022.100061","volume":"6","author":"R Ajideh","year":"2022","unstructured":"Ajideh R, Pourmand MR, Faramarzi MA, Sepehrizadeh Z, Pourmand G, Hassanzadeh SM, et al. Potentiation of the therapeutic effect of intravesical BCG through synthetic and biogenic selenium nanoparticles in a nitrosamine-induced bladder cancer mouse model. Adv Cancer Biol Metast. 2022;6: 100061.","journal-title":"Adv Cancer Biol Metast"},{"key":"2758_CR51","doi-asserted-by":"publisher","first-page":"4405","DOI":"10.1021\/acs.jafc.7b00896","volume":"65","author":"C Liu","year":"2017","unstructured":"Liu C, Fu Y, Li C-e, Chen T, Li X. Phycocyanin-functionalized selenium nanoparticles reverse palmitic acid-induced pancreatic \u03b2 cell apoptosis by enhancing cellular uptake and blocking reactive oxygen species (ROS)-mediated mitochondria dysfunction. J Agri Food Chem. 2017;65:4405\u201313.","journal-title":"J Agri Food Chem"},{"key":"2758_CR52","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1039\/C8BM00670A","volume":"6","author":"G Huang","year":"2018","unstructured":"Huang G, Liu Z, He L, Luk K-H, Cheung S-T, Wong K-H, et al. Autophagy is an important action mode for functionalized selenium nanoparticles to exhibit anti-colorectal cancer activity. Biomater Sci. 2018;6:2508\u201317.","journal-title":"Biomater Sci"},{"key":"2758_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12951-017-0276-3","volume":"15","author":"P Sonkusre","year":"2017","unstructured":"Sonkusre P, Cameotra SS. Biogenic selenium nanoparticles induce ROS-mediated necroptosis in PC-3 cancer cells through TNF activation. J Nanobiotechnol. 2017;15:1\u201312.","journal-title":"J Nanobiotechnol"},{"key":"2758_CR54","first-page":"1125","volume":"8","author":"KK Vekariya","year":"2012","unstructured":"Vekariya KK, Kaur J, Tikoo K. ER\u03b1 signaling imparts chemotherapeutic selectivity to selenium nanoparticles in breast cancer. Nanomedicine: Nanotechnology. Biol Med. 2012;8:1125\u201332.","journal-title":"Biol Med"},{"key":"2758_CR55","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.lfs.2016.02.042","volume":"148","author":"V Jadhav","year":"2016","unstructured":"Jadhav V, Ray P, Sachdeva G, Bhatt P. Biocompatible arsenic trioxide nanoparticles induce cell cycle arrest by p21WAF1\/CIP1 expression via epigenetic remodeling in LNCaP and PC3 cell lines. Life Sci. 2016;148:41\u201352.","journal-title":"Life Sci"},{"key":"2758_CR56","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.neulet.2009.12.073","volume":"470","author":"H Kitazawa","year":"2010","unstructured":"Kitazawa H, Numakawa T, Adachi N, Kumamaru E, Tuerxun T, Kudo M, et al. Cyclophosphamide promotes cell survival via activation of intracellular signaling in cultured cortical neurons. Neurosci Lett. 2010;470:139\u201344.","journal-title":"Neurosci Lett"},{"key":"2758_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s11658-018-0074-4","volume":"23","author":"Y Sun","year":"2018","unstructured":"Sun Y, Wang C, Wang L, Dai Z, Yang K. Arsenic trioxide induces apoptosis and the formation of reactive oxygen species in rat glioma cells. Cell Mol Biol Lett. 2018;23:1\u201310.","journal-title":"Cell Mol Biol Lett"},{"key":"2758_CR58","first-page":"4115","volume":"20","author":"G Bauer","year":"2000","unstructured":"Bauer G. Reactive oxygen and nitrogen species: efficient, selective, and interactive signals during intercellular induction of apoptosis. Anticancer Res. 2000;20:4115\u201339.","journal-title":"Anticancer Res"},{"key":"2758_CR59","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1038\/sj.onc.1210220","volume":"26","author":"JM Adams","year":"2007","unstructured":"Adams JM, Cory S. The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene. 2007;26:1324\u201337.","journal-title":"Oncogene"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-02758-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-025-02758-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-02758-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T04:06:51Z","timestamp":1748664411000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-025-02758-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,10]]},"references-count":59,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["2758"],"URL":"https:\/\/doi.org\/10.1007\/s12032-025-02758-6","relation":{},"ISSN":["1559-131X"],"issn-type":[{"type":"electronic","value":"1559-131X"}],"subject":[],"published":{"date-parts":[[2025,5,10]]},"assertion":[{"value":"16 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"207"}}